A rural clinic decides how to screen for colorectal cancer
You are the sole clinician at a rural clinic with 1,200 adult patients, no on-site endoscopy, and a 3-week wait for the nearest colonoscopy center 90 minutes away. Budget allows either (a) mailed FIT kits with navigation, or (b) an annual colonoscopy referral drive. Local data: 38% of eligible patients are up to date on screening; FIT return rate in similar clinics is about 55%; colonoscopy completion after a positive FIT is about 60% because of transportation and scheduling barriers. Two patients this month declined colonoscopy but asked about 'the stool test.' A 52-year-old asymptomatic patient with a family history of colon cancer in his father at age 62 asks which test he should do.
1. Compare the two strategies for this population using the concepts of sensitivity, specificity, and program-level effectiveness, and explain why test accuracy alone does not decide the question.
Read the worked answer
Test characteristics:
- FIT detects hemoglobin; it is specific for bleeding lesions but has limited sensitivity for non-bleeding adenomas and right-sided lesions, and requires annual completion. Its performance depends on the follow-up colonoscopy after a positive result - a positive FIT that is never followed up provides no benefit and can cause harm through anxiety and false reassurance.
- Colonoscopy is the reference standard with high sensitivity and specificity and allows polypectomy, but its population benefit depends on uptake and completion.
Program-level reasoning:
- With 38% baseline screening, a mailed FIT program with navigation can plausibly raise participation substantially; even at 55% return, that is more people screened than a referral drive that depends on patients traveling 90 minutes.
- But the 60% follow-up rate after positive FIT is the weak link: a positive FIT is only useful if colonoscopy follows. The program must include navigation, transportation support, and tracking.
- Colonoscopy has higher per-test accuracy but lower realized uptake in this setting.
Conclusion: choose the strategy that maximizes the number of people screened and the number of positive results appropriately followed up, not the one with the best single-test accuracy. A hybrid - mailed FIT with a robust positive-result navigation pathway - is likely most effective here.
2. How should you counsel the 52-year-old with a family history, and how does his risk change the choice?
Read the worked answer
Family history changes both when and how to screen:
- A first-degree relative with colorectal cancer at age 62 is diagnosed at ≥60, so guidance is generally to begin screening at age 40 or 10 years before the relative's diagnosis, whichever is earlier, and to repeat at intervals determined by findings - commonly colonoscopy every 5 years (some guidelines use 10 years if the relative was ≥60 and no personal findings). Because he is already 52, he is due now.
- For patients with a family history, colonoscopy is generally preferred because it is both diagnostic and therapeutic and is not subject to FIT's lower sensitivity for adenomas.
- If he declines colonoscopy, FIT is a reasonable interim option, but he should understand its limitations and that a positive result mandates colonoscopy.
Counseling should be shared decision-making: explain his elevated risk, that colonoscopy is the preferred test in his case, and address the practical barriers (transportation, scheduling) that underlie his hesitation.
3. Design the minimal quality metrics the clinic should track to know whether the chosen program is working, and explain what each metric would reveal.
Read the worked answer
Track metrics across the screening cascade, not just kits mailed:
- Screening uptake - proportion of eligible patients up to date (FIT returned or colonoscopy completed) within 12 months. Reveals reach.
- FIT return rate - proportion of distributed kits returned. Reveals whether navigation and reminders work.
- Colonoscopy completion after positive FIT - the critical bottleneck (currently ~60%). Reveals whether the program converts positives into diagnoses; a low value means the program is generating anxiety and cost without benefit.
- Time from positive FIT to colonoscopy - delays reduce benefit and increase loss to follow-up.
- Detection yield - adenomas and cancers found per 100 colonoscopies, to confirm the program is finding disease.
- Equity check - uptake by insurance, language, and distance, so the program does not widen disparities.
A program that raises uptake but leaves follow-up at 60% is not succeeding; the metric set should force attention to that step.